Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Integral Molecular
AddedFeb 15, 2024
UpdatedJun 18, 2026
Integral Molecular

Integral Molecular

Philadelphia-based Integral Molecular is a biotech firm innovating therapeutic antibodies and technologies.

HQ
Philadelphia, PA, US
Founded
2001
Overview
Compare
Fundraising
Employees
Website

Founded in Philadelphia, Integral Molecular is a biotechnology company dedicated to creating innovative technologies and developing therapeutic antibodies. The company's core mission is to advance the discovery and development of treatments targeting membrane proteins, which are crucial for many biological processes and diseases. Integral Molecular offers a range of products and services, including virus neutralization assay services and validated reagent antibodies, focusing on supporting vaccine development and antibody discovery.

Integral Molecular has achieved significant milestones, such as obtaining ISO certification for its virology critical reagents. The company has also launched a spin-out focused on validated reagent antibodies. Its impact is evident in its contributions to breaking barriers in antibody discovery and supporting global health initiatives through advanced biotechnological solutions. Notable investors and affiliated individuals have not been specified, but the company's achievements underscore its role as an industry leader in membrane protein solutions.

Integral Molecular - Similar Companies

MSM Protein Technologies logo

MSM Protein Technologies

msmprotein.com

Indi Molecular logo

Indi Molecular

indimolecular.com

OmniAb logo

OmniAb

omniab.com

Idbiologics logo

Idbiologics

idbiologics.com

AltruBio logo

AltruBio

Initial Therapeutics logo

Initial Therapeutics

initialtx.com

EpiBiologics logo

EpiBiologics

epibiologics.com

ImmuneXcite logo

ImmuneXcite

Macromoltek logo

Macromoltek

macromoltek.com

Immuto Scientific logo

Immuto Scientific

Global Bio logo

Global Bio

ABclonal logo

ABclonal

abclonal.com

Molecular Templates logo

Molecular Templates

Abreos Biosciences logo

Abreos Biosciences

abreos.com

Intact Genomics logo

Intact Genomics

intactgenomics.com

Integral Molecular - Quick Facts

Who are Integral Molecular's competitors?

Companies similar to Integral Molecular include MSM Protein Technologies, Indi Molecular, OmniAb and Idbiologics.

When was Integral Molecular founded?

Integral Molecular was founded in 2001.

Where is Integral Molecular's headquarters located?

Integral Molecular's headquarters is located in Philadelphia, PA, US.

When was Integral Molecular's last funding round?

Integral Molecular's most recent funding round was for $900k (USD) in October 2023.

How much has Integral Molecular raised to-date?

As of Oct 5, 2023, Integral Molecular has raised a total of $13.4M (USD).

How many employees does Integral Molecular have?

Integral Molecular has 30 employees as of Feb 4, 2024.

Integral Molecular - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Antibodies
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 8733Noncommercial Research Organizations
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified